Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Obesity in children can worsen skin issues and increase infection risk.

Children with metabolic syndrome often have skin problems like dark patches, skin tags, stretch marks, infections, acne, and psoriasis, which are linked to obesity and insulin resistance.

Topical oxygen therapy may improve treatments for hair loss, acne, and chronic skin diseases with minimal side effects.

Botulinum toxin shows promise for treating skin conditions but needs more research for safety and effectiveness.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

New psoriasis treatments are effective but come with side effects and risks.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Scoring systems help doctors assess and treat skin diseases effectively.

Higher BMI may increase the risk of psoriasis and some other skin diseases.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Narrowband Ultraviolet B treatment can significantly reduce anxiety in psoriasis patients, but it doesn't significantly affect depression.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

Venusia CeraPlus cream and lotion effectively reduce eczema severity and improve skin moisture.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

Videodermoscopy can help diagnose and monitor nail bed psoriasis.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Higher inflammation markers are linked to more severe alopecia areata.

Alopecia areata affects life quality differently based on its severity.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Nutrition plays a key role in managing skin disorders, with specific dietary changes helping improve conditions like acne, dermatitis, psoriasis, alopecia, and skin cancer.